(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

VELABS

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

VELABS

ST13

US500000079235883

Classe

5, 9, 42, 44

Pedido

79235883

Registro

5853764

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

46

Atualização mais recente

21/04/2026

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 9, 42, 44

Data de depósito

18/04/2018

Data de registro

10/09/2019

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

27/03/2026

Última transação

21/04/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Heidelberg, CH

Examinador

LAM, HAI-LY HUYNH

Unidade examinadora

M30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

E. L. (pessoa física)

Representantes

Nicholas D. Wells Legends Law Group, PLLC

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Antibodies for medical usefor diagnostic testing and therapeutic intervention; blood productsimmunoglobulins for medical use; vaccines; scaffold-proteins for medical use; cell-based assays for medical usefor screening and testing of body fluids and cells therein; veterinary preparationsfor the treatment of infectious and metabolic diseases; medical preparations for the treatment of cancerousinfectious and metabolic diseases and for the prevention and treatment of allergies; pharmaceuticals for the treatment of rare diseasesfor the treatment of infectious diseasesfor use in oncologyfor the treatment of metabolic diseases

Classe 9

Scientificopticalmeasuring apparatus and instrumentsoptical mirrorslasers not for medical usemicrofluidic chips not for medical use; data processing equipment; computer software for database managementfor measuring of droplet particle flow rates and fluorescencefor sorting and filtering of droplet particles according to filter rulesfor data visualizationfor use as a spreadsheet; laboratory equipmentmicrofluidic chips and laboratory swabs

Classe 42

Scientific and technological servicesscientific testing and screening of cell and molecule reservoirs against target proteins in the fields of pharmaceuticals and biochemicals and new product research and design relating thereto; industrial analysis and research services in the fields of pharmaceuticals and biochemicals; design and development of computer hardware and software; scientific research services using high throughput screening methods; drug discovery services; antibody screening services for scientific research purposes; vaccine screening services for scientific research purposes

Classe 44

Medical services; medical diagnostic testingmonitoring and reporting services and medical screening services; medical screening of patient-derived antibodies; personalized medicine information services

Publicações

Histórico de despachos e eventos da marca no USPTO.

46 publicações encontradas

C71T

CANCELLED SECTION 71

27/03/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

30/01/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

30/01/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

30/01/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

30/01/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

30/01/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

30/01/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

29/11/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

10/09/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

31/01/2020

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/01/2020

FIMP

FINAL DISPOSITION PROCESSED

09/01/2020

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/12/2019

R.PR

REGISTERED-PRINCIPAL REGISTER

10/09/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

25/06/2019

PUBO

PUBLISHED FOR OPPOSITION

25/06/2019

GPNX

NOTIFICATION PROCESSED BY IB

21/06/2019

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

05/06/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/06/2019

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

05/06/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

21/05/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

21/05/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/05/2019

ALIE

ASSIGNED TO LIE

17/05/2019

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

10/05/2019

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

25/04/2019

GNFR

FINAL REFUSAL E-MAILED

25/04/2019

CNFR

FINAL REFUSAL WRITTEN

25/04/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/04/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/04/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/04/2019

NAUD

NOTICE OF UNRESPONSIVE AMENDMENT - MAILED

18/03/2019

NAUD

REPORT UNRESPONSIVE AMENDMENT - COMPLETED

16/03/2019

ACEC

AMENDMENT FROM APPLICANT ENTERED

25/02/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

25/02/2019

ALIE

ASSIGNED TO LIE

19/02/2019

FAXX

FAX RECEIVED

13/02/2019

RFNT

REFUSAL PROCESSED BY IB

08/09/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

22/08/2018

RFRR

REFUSAL PROCESSED BY MPU

22/08/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

11/08/2018

CNRT

NON-FINAL ACTION WRITTEN

10/08/2018

DOCK

ASSIGNED TO EXAMINER

07/08/2018

MAFR

APPLICATION FILING RECEIPT MAILED

11/07/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/07/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/07/2018

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace VELABS ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.